Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allurion Technologies (ALUR)
NYSE:ALUR
RESEARCH TOOLSreports
Holding ALUR?
Track your performance easily
ALUR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.31 - $4.24
Previous Close$0.46
Volume621.70K
Average Volume (3M)228.30K
Market Cap
$30.75M
Enterprise Value$36.31M
Total Cash (Recent Filing)$28.65M
Total Debt (Recent Filing)$38.55M
Price to Earnings (P/E)―
Beta1.76
Next Earnings
Mar 20, 2025EPS Estimate
-$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding64,486,517
10 Day Avg. Volume472,280
30 Day Avg. Volume228,299
Standard Deviation0.19
R-Squared0.22
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.46
Price to Sales (P/S)1.00
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.81
Enterprise Value/Gross Profit0.87
Enterprise Value/Ebitda-1.05
Forecast
1Y Price Target
$2.00Price Target Upside275.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Allurion Technologies News
PremiumCompany Announcements
Allurion Technologies Reports Q3 2024 Financial Performance
PremiumCompany Announcements
Allurion Technologies CFO Resigns, CEO Steps InBulls Say, Bears Say
Bulls Say
Commercial ExpansionPositive data from the Audacity trial should enable FDA approval, positioning ALUR's balloon for entry into the US market, which is an $18B opportunity.
Market OpportunityThe company's intragastric balloon paired with a virtual care suite is a procedure-less intervention that drives durable weight loss, with a tenfold lower rate of serious adverse events.
Product ApprovalPositive results in Audacity will greatly increase the Allurion Balloon's prospects for US approval and should be a major positive stock catalyst.
Bears Say
Guidance RevisionThe company has updated its 2024 guidance and now expects revenue of $30M-$35M compared to $40M-$45M previously.
Market ChallengesSales in the third quarter were affected by macroeconomic challenges in certain markets, inventory reductions, and revenue impacts tied to a recall in France.
Revenue ShortfallThird-quarter revenue fell short of expectations with revenue reported at $5.4M compared to the $8.6M consensus.
---
Ownership Overview
1.88% Insiders
1.38% Mutual Funds
22.04% Other Institutional Investors
72.83% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ALUR FAQ
What was Allurion Technologies’s price range in the past 12 months?
Allurion Technologies lowest stock price was $0.31 and its highest was $4.24 in the past 12 months.
What is Allurion Technologies’s market cap?
Currently, no data Available
When is Allurion Technologies’s upcoming earnings report date?
Allurion Technologies’s upcoming earnings report date is Mar 20, 2025 which is in 119 days.
How were Allurion Technologies’s earnings last quarter?
Allurion Technologies released its earnings results on Nov 13, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.182 by $0.042.
Is Allurion Technologies overvalued?
According to Wall Street analysts Allurion Technologies’s price is currently Undervalued.
Does Allurion Technologies pay dividends?
Allurion Technologies does not currently pay dividends.
What is Allurion Technologies’s EPS estimate?
Allurion Technologies’s EPS estimate is -$0.22.
How many shares outstanding does Allurion Technologies have?
Allurion Technologies has 64,486,520 shares outstanding.
What happened to Allurion Technologies’s price movement after its last earnings report?
Allurion Technologies reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.182. Following the earnings report the stock price went down -26.761%.
Which hedge fund is a major shareholder of Allurion Technologies?
Among the largest hedge funds holding Allurion Technologies’s share is Fortress Investment Group LLC. It holds Allurion Technologies’s shares valued at 773K.
---
Allurion Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (275.30% Upside)
$2.00 (275.30% Upside)
Blogger Sentiment
Bullish
ALUR Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 12.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 16.2%
Last 30 Days ▲ 16.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.78%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-57.99%
Trailing 12-Months
Company Description
Allurion Technologies
Compute Health Acquisition Corp is a blank check company.
---
ALUR Earnings Call
Q3 2024
0:00 / 0:00
---
ALUR Stock 12 Month Forecast
Average Price Target
$2.00
▲(275.30% Upside)
Technical Analysis
Best Analysts Covering ALUR
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-34.40%
reiterated a buy rating 9 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -34.40% per trade.
---